Drake & Associates’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.46M | Buy |
7,859
+48
| +0.6% | +$8.91K | 0.36% | 40 |
|
|
2025
Q1 | $1.64M | Sell |
7,811
-14
| -0.2% | -$2.93K | 0.46% | 32 |
|
|
2024
Q4 | $1.49M | Buy |
7,825
+513
| +7% | +$97.8K | 0.42% | 27 |
|
|
2024
Q3 | $1.44M | Buy |
7,312
+300
| +4% | +$59.2K | 0.47% | 20 |
|
|
2024
Q2 | $1.2M | Sell |
7,012
-185
| -3% | -$31.7K | 0.43% | 21 |
|
|
2024
Q1 | $1.31M | Hold |
7,197
| – | – | 0.48% | 21 |
|
|
2023
Q4 | $1.12M | Hold |
7,197
| – | – | 0.46% | 21 |
|
|
2023
Q3 | $1.07M | Sell |
7,197
-298
| -4% | -$44.4K | 0.49% | 21 |
|
|
2023
Q2 | $1.01M | Buy |
7,495
+23
| +0.3% | +$3.1K | 0.45% | 22 |
|
|
2023
Q1 | $1.19M | Sell |
7,472
-43
| -0.6% | -$6.85K | 0.58% | 18 |
|
|
2022
Q4 | $1.21M | Buy |
+7,515
| New | +$1.21M | 0.64% | 18 |
|